Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-10, Vol.27, p.vi345-vi345 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | vi345 |
|---|---|
| container_issue | |
| container_start_page | vi345 |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Seront, E. Schmitz, S. Rottey, S. Henry, S. Lonchay, C. van Caloen, G. Gilain, A. Machiels, J.-P. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw376.54 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw376_54</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419446292</els_id><sourcerecordid>S0923753419446292</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3214-57702d70b32e08549201653df918640ab3dfe65ec9c174d165e82b607e48edfd3</originalsourceid><addsrcrecordid>eNp1kEtPwzAQhC0EEqVw57h_IK0d23lwQxWPSpXgAOfIsTeKIY9iO5Te-Om4lCun3dXoG-0MIdeMLhgt-VINwzjoZW92PM8WUpyQGZNZmRRUsFMyo2XKk1xycU4uvH-jlGZlWs7I93OrPMIafJjMHsYGnK1HbXVna9h2kweNYfqyvarBDrBVweIQPOxsaMGhnpyLN4wOegzKh6hr8B-T6sdftutAK6ftMPbq4B5ahBaVATUYGFC_X5KzRnUer_7mnLze372sHpPN08N6dbtJNE-ZSGSe09TktOYp0kKKMqUsk9w0JSsyQVUdV8wk6lKzXJioYZHWGc1RFGgaw-eEHn21G7132FRbF1O5fcVodWiwOjZYHRuspIjIzRHB-NenRVd5HdNrNDYmD5UZ7f_wD9h0fYM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Seront, E. ; Schmitz, S. ; Rottey, S. ; Henry, S. ; Lonchay, C. ; van Caloen, G. ; Gilain, A. ; Machiels, J.-P.</creator><creatorcontrib>Seront, E. ; Schmitz, S. ; Rottey, S. ; Henry, S. ; Lonchay, C. ; van Caloen, G. ; Gilain, A. ; Machiels, J.-P.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw376.54</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi345-vi345</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3214-57702d70b32e08549201653df918640ab3dfe65ec9c174d165e82b607e48edfd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids></links><search><creatorcontrib>Seront, E.</creatorcontrib><creatorcontrib>Schmitz, S.</creatorcontrib><creatorcontrib>Rottey, S.</creatorcontrib><creatorcontrib>Henry, S.</creatorcontrib><creatorcontrib>Lonchay, C.</creatorcontrib><creatorcontrib>van Caloen, G.</creatorcontrib><creatorcontrib>Gilain, A.</creatorcontrib><creatorcontrib>Machiels, J.-P.</creatorcontrib><title>Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kEtPwzAQhC0EEqVw57h_IK0d23lwQxWPSpXgAOfIsTeKIY9iO5Te-Om4lCun3dXoG-0MIdeMLhgt-VINwzjoZW92PM8WUpyQGZNZmRRUsFMyo2XKk1xycU4uvH-jlGZlWs7I93OrPMIafJjMHsYGnK1HbXVna9h2kweNYfqyvarBDrBVweIQPOxsaMGhnpyLN4wOegzKh6hr8B-T6sdftutAK6ftMPbq4B5ahBaVATUYGFC_X5KzRnUer_7mnLze372sHpPN08N6dbtJNE-ZSGSe09TktOYp0kKKMqUsk9w0JSsyQVUdV8wk6lKzXJioYZHWGc1RFGgaw-eEHn21G7132FRbF1O5fcVodWiwOjZYHRuspIjIzRHB-NenRVd5HdNrNDYmD5UZ7f_wD9h0fYM</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Seront, E.</creator><creator>Schmitz, S.</creator><creator>Rottey, S.</creator><creator>Henry, S.</creator><creator>Lonchay, C.</creator><creator>van Caloen, G.</creator><creator>Gilain, A.</creator><creator>Machiels, J.-P.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck</title><author>Seront, E. ; Schmitz, S. ; Rottey, S. ; Henry, S. ; Lonchay, C. ; van Caloen, G. ; Gilain, A. ; Machiels, J.-P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3214-57702d70b32e08549201653df918640ab3dfe65ec9c174d165e82b607e48edfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seront, E.</creatorcontrib><creatorcontrib>Schmitz, S.</creatorcontrib><creatorcontrib>Rottey, S.</creatorcontrib><creatorcontrib>Henry, S.</creatorcontrib><creatorcontrib>Lonchay, C.</creatorcontrib><creatorcontrib>van Caloen, G.</creatorcontrib><creatorcontrib>Gilain, A.</creatorcontrib><creatorcontrib>Machiels, J.-P.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seront, E.</au><au>Schmitz, S.</au><au>Rottey, S.</au><au>Henry, S.</au><au>Lonchay, C.</au><au>van Caloen, G.</au><au>Gilain, A.</au><au>Machiels, J.-P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi345</spage><epage>vi345</epage><pages>vi345-vi345</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw376.54</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-10, Vol.27, p.vi345-vi345 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw376_54 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T20%3A04%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20I%20study%20of%20ribociclib%20plus%20cetuximab%20in%20patients%20with%20recurrent%20or%20metastatic%20squamous%20cell%20carcinoma%20of%20the%20head%20and%20neck&rft.jtitle=Annals%20of%20oncology&rft.au=Seront,%20E.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi345&rft.epage=vi345&rft.pages=vi345-vi345&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw376.54&rft_dat=%3Celsevier_cross%3ES0923753419446292%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419446292&rfr_iscdi=true |